Ординатура / Офтальмология / Английские материалы / Optical Coherence Tomography in Age-Related Macular Degeneration_Coscas_2009
.pdf
180 Chapter 8 · Clinical Features and Natural History of AMD
The presence of reticular drusen (especially visible in blue light) adjacent to the temporal arcades is an additional risk factor for wet AMD. They are hardly seen on TD-OCT sections of perimacular zones.
These reticular drusen are much more clearly visible on SD-OCT and enlarged views, which show a thickening band and undulations of the RPE but with no alteration of the outer nuclear layer (Figure 6).
Drusen and Outer Retinal Layers
Moreover, one of the major advantages of SD-OCT is to visualize reactions in the outer retinal layers when present.
8
As drusen increase in size, they raise the RPE band, IS/ OS interface, and external limiting membrane, which then can appear irregular, thinned, and disrupted. The outer nuclear layer can also be modified, thinned, and invaded by a homogeneous or jagged moderately reflective zone (Figure 6).
These alterations reflect damage to inner and outer segments and photoreceptors as a whole over the largest drusen. They therefore constitute valuable signs of the impact of drusen and possible photoreceptor damage
Analysis of drusen is based not only on anteroposterior scans, but also on 3D scans. Future clinical trials of drusen volume measurements will allow even more reliable quantitative assessment of their course (Figure 7).
Natural History
Atrophy
Drusen usually progress towards atrophy as the material regresses and is replaced by a zone of atrophy of the RPE (Figure 8). Atrophy can be seen on monochromatic images and especially on red-free images.
On fluorescein angiography, RPE atrophy causes hyperfluorescence due to a window defect with late and progressive staining, while atrophy is hypo-fluorescent on ICG angiography.
The OCT examination easily confirms the diagnosis of RPE atrophy by showing thinning of the RPE band associated with thinning or even loss of the outer retinal layers.
These areas of atrophy replace perifoveal drusen and then gradually spread to the center of the macula causing loss of vision (Figure 9).
Drusenoid PED
Soft drusen usually increase in size and become confluent, resulting in the appearance of a drusenoid PED (Figure 10). Biomicroscopic findings are already suggestive with a wavy, irregular elevation and pigment migration, which can be star-shaped or web-shaped.
On fluorescein angiography, hypo-fluorescence due to pigment migration and xanthophyll pigment contrast with the zone of progressive hyper-fluorescence corresponding to the drusenoid PED.
However, on SLO-ICG angiography, drusenoid PEDs and the surrounding soft drusen remain hypo-fluorescent even in late images.
On OCT, the RPE band is elevated with gently sloping or sometimes wavy edges. The underlying drusenoid material is usually moderately hyper-reflective and Bruch’s membrane becomes visible.
Pigment migrations induce zones of fairly intense hyperreflectivity that alter and sometimes disrupt the IS/OS interface and external limiting membrane. They can also extend into the retina, causing localized disorganization (Figure 11).
Neovascular Complications
Drusen may evolve spontaneously to choroidal neovascularization, which can be characterized by fluorescein leakage. The presence or absence of leakage on fluorescein angiography and the presence of subretinal or intraretinal fluid on OCT are the most reliable diagnostic signs.
OCT can also demonstrate slight intraretinal fluid, even at a subclinical stage. This would suggest the presence of choroidal neovascularization. OCT should therefore be considered in all patients with soft, confluent drusen or a drusenoid PED who present with functional changes such as metamorphopsias or vision loss
CNV can lead to the formation of a vascularized PED, precisely detectable on OCT, as illustrated by the following example (clinical case No. 1, page 184, Figures 12, 13, and 14).
Chapter 8 · Clinical Features and Natural History of AMD |
181 |
8 |
|
||
|
|
|
RETICULAR PSEUDO-DRUSEN
Reticular Pseudo-drusen
External Limiting Membrane
Interface
Reticular Pseudo-drusen
Figure 6: Reticular drusen visible in blue light and on autofluorescence (VA: 20/32).
a): Spectralis* eccentric vertical section correlated with an autofluorescence image (numerous reticular pseudo-drusen with a polypoid appearance in the region of the temporal arcades, also visible in blue light).
On SD-OCT, these lesions are seen as a series of localized thickenings of the RPE, raising the IS/OS interface and external limiting membrane but with no breaks or change in thickness of these lines.
b): Enlarged images of the SD-OCT image confirming the absence of alteration of the outer nuclear layer.
3D IMAGE OF DRUSEN
Figure 7: 3D image of drusen (Topcon*). Each SD-OCT section can be analyzed by comparison with the fundus image and studied frame by frame or as a video sequence.
182 Chapter 8 · Clinical Features and Natural History of AMD
DRUSEN AND ATROPHIC ZONES
a |
Localized atrophy |
b
8
Atrophy
Figure 8: Soft drusen: natural progression to atrophy (VA: 20/50).
a): Spectralis* horizontal section correlated with a monochromatic image and fluorescein angiography: numerous soft drusen some of which have resulted in atrophy.
On SD-OCT, loss of drusen in the atrophic area, thinning of the RPE, loss of the external limiting membrane and IS/OS interface and alteration of the outer nuclear layer.
The inner layers of the retina remain almost normal.
b): Enlargement of the SD-OCT image confirming changes in the outer retinal layers.
a |
RPE and external retinal layers atrophy |
b
Figure 9: Numerous soft drusen and perifoveal atrophic areas.
a and b): Spectralis* horizontal and vertical sections correlated with fluorescein angiography and ICG angiography (most of the soft drusen have been replaced by areas of perifoveal atrophy and atrophy of the outer layers).
On SD-OCT, numerous soft drusen associated with irregularities of the RPE and areas of atrophy with loss of the RPE and outer retinal layers and marked posterior hyper-reflectivity.
Chapter 8 · Clinical Features and Natural History of AMD |
183 |
8 |
|
||
|
|
|
DRUSENOID PED
a |
b |
c |
d |
Drusenoid DEP |
Outer nuclear layer |
|
alteration |
||
|
e
Figure 10: Confluent soft drusen with a small drusenoid PED (VA: 20/25). a-d): Color photograph, fluorescein angiography, SLO-ICG, and Stratus* OCT.
e): Spectralis* horizontal section : this small, regular dome-shaped juxtafoveal drusenoid PED (thin arrow) has a less reflective cavity, allowing good visualization of Bruch’s membrane.
Note the adjacent alterations of the IS/OS interface and the denser zone that invades the outer nuclear layer. This abnormality can also be seen on Stratus* OCT (arrow).
a Drusenoid DEP and material deposits
b
Figure 11: Small drusenoid PED and deposits (VA: 20/63).
a): Spectralis* horizontal section correlated with fluorescein angiography (numerous soft drusen with a central hypo-fluorescent area).
On SD-OCT, numerous tightly packed soft drusen of various sizes, causing changes in the photoreceptor layer and decreased thickness of the outer nuclear layer over the large drusen.
b): Spectralis* horizontal section correlated with ICG angiography (numerous large, hypo-fluorescent, confluent soft drusen, especially in the center, forming a small drusenoid PED).
On SD-OCT, the IS/OS interface appears to be thickened over the dome of the drusenoid PED, the outer nuclear layer is partially displaced or thinned and deposits have invaded the outer retinal layers.
184 Chapter 8 · Clinical Features and Natural History of AMD
CLINICAL CASE No. 01 MIXED DRUSEN AND CNV
Clinical Signs
A 75-year-old patient followed for decompensation of occult CNV in his first eye, presented with the absence of any symptoms, signs of ARM on routine examination of the fellow eye. This eye had fairly numerous, tightly packed mostly hard drusen of various sizes. The largest drusen are slightly autofluorescent. VA RE: 20/32 - VA LE: 20/20.
Angiography shows rapid and early staining of numerous hard drusen, sometimes in clusters or even confluent and sero-granular. Soft drusen are not stained at
8this stage. There is no fluorescein leakage.
SLO-ICG shows the presence of a small number of dark, hypo-fluorescent perifoveal soft drusen.
At this stage, these lesions therefore correspond to mixed, predominantly hard drusen without complications (Figure 12a-d).
Six Months Later
The patient reported moderate symptoms with minimal metamorphopsias and moderate loss of visual acuity in the left eye (20/32).
Biomicroscopic examination revealed a recently developed, moderately dense macular hemorrhage measuring 1/2 disc diameter with a relatively flat, eccentric SRF which was clearly visible on autofluorescence.
On angiography, an irregular hyper-fluorescent area with pinpoint leakage occupied the nasal half of the fovea, with diffuse fluorescein leakage. This lesion was lined by hemorrhage. SLO-ICG showed a dark PED, which was seen as hyper-fluorescence of an occult choroidal neovascularization.
Suggested Diagnosis:
Recent occult CNV with hemorrhage detected dur-
ing routine follow-up of mixed drusen (Figure 13a,
b, and c).
Autofluorescence a
FA |
b |
SLO-ICG c
Figure 12a, b, and c): mixed Drusen with no complications during the observation period.
Autofluorescence a
FA |
b |
SLO-ICG |
c |
|
Hemorrhage |
|
|
Figure 13a, b, and c): six months later: occult choroidal neovascularization with hemorrhagic complications.
Chapter 8 · Clinical Features and Natural History of AMD |
185 |
8 |
|
||
|
|
|
a
Hyper reflectivity in front of RPE
b
PED
Figure 14a): hard drusen and several soft drusen without complications. b): six months later, minimal PED with hemorrhagic neovascularization.
Contribution of OCT
During Follow-Up
Stratus* horizontal section: almost normal appearance (Figure 14a).
At the level of the RPE band: several irregularities and limited elevations of the RPE with no posterior shadowing and with poorly reflective material, suggesting small soft drusen. No hard drusen are visible.
Posterior to the RPE: no alteration.
Anterior to the RPE: retinal layers have a normal appearance. Note the slight asymmetry of the hypo-reflective zone corresponding to Henle fibers.
Six Months Later
Stratus* horizontal section: appearance highly suggestive of CNV (Figure 14b).
At the level of the RPE band: moderate but regular elevation of the hyper-reflective band of the RPE.
Posterior to the RPE: the PED cavity is slightly reflective allowing visualization of Bruch’s membrane.
Anterior to the RPE: diffuse increase of retinal thickness and presence of subfoveal hyper-reflective material, which probably corresponds to retinal hemorrhage.
Diagnosis
The OCT examination demonstrated a limited PED
(corresponding to the hypo-fluorescent area visible
on SLO-ICG angiography).
The PED appears to be relatively flat but is characterized by the visibility of Bruch’s membrane, which has become distinct from the RPE.
A small amount of intraretinal fluid can be seen ante-
rior to the RPE with increased retinal thickness, which is especially visible in the nasal sector.
In the central zone, the hypo-reflective band of the outer nuclear layer is thinned and partially displaced by a hyper-reflective zone, probably corresponding to
retinal hemorrhage.
These signs are suggestive of a small zone of subfo-
veal classic CNV.
Fluorescein angiography confirms the presence of
CNV by showing more marked localized hyper-fluo- rescence in this zone with fluorescein leakage.
On ICG angiography, the PED is localized and clearly visible. The sub-RPE fluid accumulation is due to leakage from occult CNV. A small area of classic CNV is also detected (but too small to show the features of a characteristic network).
This “minimally classic” CNV shows signs of recent decompensation, confirmed by hemorrhage, fluorescein leakage, the dark PED on ICG angiography, elevation of the RPE band on OCT, and moderate loss of visual acuity.
Anti-VEGF intravitreal injection is indicated, which
has to be followed regularly by VA and imaging.
186 Chapter 8 · Clinical Features and Natural History of AMD
Follow-Up
The proposed treatment of monthly intravitreous injections of anti-VEGF (Lucentis*) was monitored each month by visual acuity, OCT, and fluorescein and ICG angiography with follow-up of one year.
Visual acuity initially declined with recurrence of symptoms during the second month then rapidly improved to become stable at 20/25 by the third month (ie, after the second injection).
A third injection of anti-VEGF was administered to
8maintain the result.
OCT
▬The thickness of the neurosensory retina decreased by the first month, but a prominent SRF, (which was confirmed with angiography) was observed after the first injection.
However, symptoms and loss of visual acuity were observed only at the third month.
The presence of a fine layer of subretinal fluid, which increased despite improvement of visual acuity, prompted continuation of treatment (Figure 15a-d).
▬At the fourth month, the situation was greatly improved with resolution of leakage and minimal persistence of a flat, partially organized PED.
▬However, one month later, recurrence of a marked SRF with signs of photoreceptor damage, justified another IVT injection (Figure 15e and f).
▬Subsequent follow-up OCT examinations showed a stable appearance with persistence of a small SRF but with no symptoms.
Despite partial normalization of the outer layers, SDOCT and the enlarged images showed signs of damage to outer segments, which had become abnormally visible and irregular at the edge of the SRF (Figure 15g and h).
The lesion appeared to have paradoxically increased in size after the first injection, extending superiorly and inferiorly.
It then stabilized with almost no change of irregular hyper-fluorescence. No signs of hemorrhage were visible, and the surface area of the lesion did not increase.
ICG Angiography
The neovascular network remained barely visible for the first 6 months. The dark PED can be seen but with poor delineation and poor contrast.
However, at the last 2 follow-up examinations, the neovascular network became more clearly visible and welldefined without an increase in size and appeared to be poorly perfused.
Conclusion
This case of drusen with a recent hemorrhagic com-
plication of minimally classic CNV illustrates rapid
subjective and objective improvement during the third month, after the second injection. Visual acuity
became 20/25 and remained stable on two successive examinations, therefore justifying temporary suspen-
sion of IVT injections.
However, a small recurrence was observed 2 months later that resolved immediately after the 4th injec-
tion. The situation then remained stable until the 12th month with no further treatment.
This improvement contrasts with the persistent SRF
observed on OCT, possibly due to fluid accumulation,
with signs of damage to outer segments, before
complete resorption.
These discordant findings indicated monthly followup.
Chapter 8 · Clinical Features and Natural History of AMD |
187 |
8 |
|
||
|
|
|
FOLLOW-UP AFTER TREATMENT
Before treatment |
VA : 20/32 |
|
a |
PED |
Hyper reflectivity |
1st month |
IVT N° 01 |
|
VA : 20/25 |
SRD
b
2nd month |
IVT N° 02 |
VA : 20//40 |
SRD
c
3th month |
IVT N° 03 |
VA : 20/25 |
d
Figure 15: Occult CNV complicating mixed drusen: follow-up after 1 year by VA, fluorescein angiography, ICG angiography, and OCT.
a): Before treatment: elevation of the RPE revealing Bruch’s membrane: increased retinal thickness; hyper-reflective subfoveal material, corresponding to the hyper-fluorescent zone with fluorescein leakage on angiography.
b): After the first IVT injection : rapid functional improvement but formation of SRF. c): 2nd month : loss of visual acuity and persistence of the SRF à 2nd IVT.
d): 3rd month: improvement of visual acuity to 20/25, no signs of SRF and complete re-attachment (vertical section) à 3rd IVT. A third IVT injection was performed to maintain the result.
188 Chapter 8 · Clinical Features and Natural History of AMD
FOLLOW-UP AFTER TREATMENT
4th month |
Reapplication |
e
5 th month |
Recurrence |
VA : 20/25 |
8
fÆIVT N° 4
12 th month
g
Outer segment alterations
SRD
h
Figure 15 (continued): Occult CNV complicating mixed drusen follow-up at 1 year by VA, fluorescein angiography, ICG angiography, and OCT.
e): 4th month: no symptoms, VA 20/25 with stable and persistent retinal re-attachment. f): 5th month: recurrence of leakage with no loss of visual acuity à 4th IVT.
g): 12th month: stable situation: no new symptoms, good visual acuity but with little change in angiographic signs and persistent SRF no further treatment.
h): Enlarged image (g) : the outer layers have returned to normal, but signs of damage to outer segments lining the SRF. Follow-up should be continued for several months.
Chapter 8 · Clinical Features and Natural History of AMD |
189 |
8 |
|
||
|
|
|
Conclusion
The various types of drusen remain the best markers of early changes in age-related maculopathy.
The clinical presentation of drusen is variable and they are also considerably, but gradually modified during the course of the disease.
Drusen have often been used to analyze the various stages of ARM in order to create a severity index, which would allow ophthalmologists to predict progression to true macular degeneration, either atrophic or especially neovascular.
Biomicroscopic examinations and counting of drusen on color fundus photographs are widely used as they are inexpensive and easy to perform.
However, drusen are more readily visible and much more numerous on red-free photographs and especially fluorescein angiography.
SLO-ICG angiography allows simple and precise visualization of soft drusen, their confluence, and their progression towards drusenoid PED.
OCT is an added advancement, which demonstrates elevation of the RPE band, visibility of Bruch’s membrane, and the homogeneous or heterogeneous appearance of drusen deposits.
Spectral-Domain OCT has provided even greater advancement, as it can be used to analyze alterations of the external limiting membrane, IS/OS interface, and the outer nuclear layer, to detect signs of photoreceptor damage.
SD-OCT 3D volume reconstruction allows calculation of drusen volume, which would be useful for statistical studies.
Drusen volume is an inexpensive and quantifiable prognostic indicator that can be used to accurately monitor the response to treatment.
SD-OCT analysis of drusen, combined with fluorescein and ICG angiography, is useful for early diagnosis of complications and to differentiate from other diagnoses, which also cause RPE atrophy or lipofuscin deposits.
